Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

DRUG(1)
MIXED(1)
2 unique interventions2 categories

Analytics

Trial Phases

Phase 21
Phase 31

Trial Status

Completed1
Terminated1

Role Distribution

Principal Investigator1
Other Roles1
PI Rate50%

Activity Timeline

Clinical Trials (2)

NCT04128319Phase 3Terminated
T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)
Steroid-Refractory Acute Graft Versus Host Disease
StudychairStart date: 2019-11-21
NCT03459040Phase 2Completed
A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD
Graft-versus-host-diseaseGVHD
PrincipalinvestigatorStart date: 2018-08-17

Research Network

Collaboration Network

5 collaborators·5 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Research Areas & Affiliations

Affiliations

Icahn School of Medicine at Mount Sinai

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Mehdi Hamadani, MD

Medical College of Wisconsin

Related
5 trials

Shared therapeutic areas:

Graft vs Host DiseaseSteroid-refractory Acute Graft Versus Host Disease

Worked with same sponsors:

Blood and Marrow Transplant Clinical Trials NetworkNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score24%

Yi-Bin Chen, MD

Massachusetts General Hospital

Related
8 trials

Shared therapeutic areas:

Graft vs Host DiseaseGVHD
Similarity Score20%

Alina Markova, MD

Memorial Sloan Kettering Cancer Center

Related
9 trials

Shared therapeutic areas:

Graft vs Host DiseaseGVHD
Similarity Score20%

Gabrielle Meyers, MD

Oregon Health and Science University

Related
1 trials

Shared therapeutic areas:

Steroid-refractory Acute Graft Versus Host Disease

Worked with same sponsors:

Blood and Marrow Transplant Clinical Trials NetworkNational Cancer Institute (NCI)+3 more
Collaborated on 1 trial
Similarity Score14%

Farid Boulad, MD

Memorial Sloan Kettering Cancer Center

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

A. John Barrett, M.D.

National Heart, Lung, and Blood Institute (NHLBI)

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score10%

Claudio G. Brunstein, MD, PhD

Masonic Cancer Center, University of Minnesota

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Cancer Institute (NCI)National Heart, Lung, and Blood Institute (NHLBI)
Similarity Score10%

Christopher James, PA

Mesoblast, Inc.

Related
7 trials

Shared therapeutic areas:

Graft vs Host Disease
Similarity Score10%

Tomasz Masior

VectivBio AG

Related
11 trials

Shared therapeutic areas:

GVHD
Similarity Score10%

Areej El-Jawahri, MD

Massachusetts General Hospital

Related
21 trials

Shared therapeutic areas:

Graft vs Host Disease

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score10%

Publications (0)

No publications found for this investigator.

Clinical Trials (2)

Showing 2 of 2 trials

NCT04128319Phase 3StudyChair

T-Guard as Treatment for Steroid Refractory Acute GVHD (BMT CTN 1802)

Steroid-Refractory Acute Graft Versus Host Disease
Terminated
NCT03459040Phase 2PrincipalInvestigator

A Proof of Concept Pilot Trial of Alpha-1-Antitrypsin for Pre-Emption Of Steroid-Refractory Acute GVHD

Graft-versus-host-diseaseGVHD
Completed

All 2 trials loaded